Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy
Research output: Contribution to journal › Article › Academic › peer-review
1Citation
(Scopus)
24Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy'. Together they form a unique fingerprint.